Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.

Novo Nordisk's Karsten Munk Knudsen is targeting 800 million obese people globally.

On a clear spring evening in Michigan, the stars aligned — just not in the way Upfront Ventures partner Nick Kim expected. He ...

We’re just over a month into 2025, and it’s already proving to be a pivotal year for TVs. The year started with a bang when, ...

The U.S. Air Force has dramatically plussed-up contracts with General Electric and Pratt & Whitney, both of which now have a ...

Pennsylvania’s emergency response system just got a major upgrade thanks to legislation passed last year to extend Next ...

Dunkin' is expanding in the Hagerstown area. A new one opened recently at Emerald Square. A proposed Dunkin' in the South End ...